- Targeted treatment of bronchogenic carcinoma2020 | First Faculty of Medicine
- Cílená léčba renálního karcinomu2016 | First Faculty of Medicine
- Recent advances in tartgeted therapy of renal cell carcinoma2016 | First Faculty of Medicine
- Targeted therapy in pulmonary medicine2016 | First Faculty of Medicine
- Cílená léčba karcinomu ovaria2016 | First Faculty of Medicine
- Vismodegib, a targeted therapy for advanced basalioma2013 | First Faculty of Medicine
- Cílená léčba ovariálního karcinomu2021 | First Faculty of Medicine
- Targeted treatment and immunotherapy of advanced non-small cell lung cancer2022 | First Faculty of Medicine
- Adverse effects of targeted cancer treatment2020 | Publication without faculty affiliation
- Immunotherapy and molecularly targeted treatment in kidney and bladder tumors2022 | First Faculty of Medicine
- Afatinib - non-small cell lung cancer in the second generation targeted therapy2014 | Publication without faculty affiliation
- Targeted therapy and immunotherapy for tumors of the gastrointestinal tract2016 | Second Faculty of Medicine
- Chemotherapy and targeted therapy for bladder cancer2019 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Phenotype-targeted treatment of COPD2014 | Faculty of Medicine in Hradec Králové
- Targeted therapy in HER2-positive breast cancer2013 | Faculty of Medicine in Hradec Králové
- Targeted treatment for breast cancer2013 | Third Faculty of Medicine
- Targeted treatment of NSCLC with kinase inhibitors - afatinib and nintedanib in clinical pracitce2017 | Faculty of Medicine in Pilsen
- Biological and targeted treatment2018 | First Faculty of Medicine, Third Faculty of Medicine
- Targeted treatment of breast cancer2016 | First Faculty of Medicine
- Advances in NSCLC therapy - actual state of the art in biological targeted therapy2013 | Publication without faculty affiliation
- Neo-/adjuvant immunotherapy and targeted therapy of non-small cell lung cancer2023 | Faculty of Medicine in Pilsen
- Crizotinib - multitargeted inhibitor in targeted NSCLC therapyPublication without faculty affiliation
- Co je nového v revmatologii na poli cílené léčby?2019 | Third Faculty of Medicine
- Dermatological side-effects of targeted cancer therapy2006 | Publication without faculty affiliation
- Use of all-trans-retinoid acid in acute promyelocytic leukemia - more than successful model of targeted treatment in hematooncology2008 | Second Faculty of Medicine
- Melanom : imunoterapie a cílená léčba2017 | Publication without faculty affiliation
- Skin adverse reactions from erlotinib2007 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Patients with neuregulin 1 (NRG1) rearranged cancer are suitable for the theranostic approach and targeted therapy2022 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Advances in targeted therapy for breast cancer2011 | First Faculty of Medicine
- Position of targeted therapy in ovarian cancer management2013 | Third Faculty of Medicine